-
- TRL (Technology readiness level) -
-
- Titre Protein involved in DNA replication, and modulation of its activity
- Description Although DNA replication is a vital process for cell growth and its mechanism is highly conserved, recent studies also reveal significant diversity in origin structure, assembly of pre-replication complex (pre-RC) and regulation of replication initiation along evolutionary lines.
It is crucial to maintain genomic integrity in eukaryotic cells. During DNA replication, errors in pre-RC assembly often result in substantial changes in the amount of genetic material, which will cause cell death, or transform cells to become malignant tumors.
The first origin recognition complex (ORC) proteins were purified from cell extracts as a heterohexameric complex that specifically binds to origins of DNA replication and the subunits were named Orc1 through Orc6.
- Bénéfices This innovation could be used for diagnosing and treating pathologies involving a deregulation of DNA replication (cancers or rare diseases as Seckel syndrome, Meier-Gorlin syndrome, Majewski osteodysplastic primordial dwarfism type II, etc.)
- Nouveauté The invention is based on the characterization by the inventors of a new protein that physically interacts with the ORC protein complex and that is involved in DNA replication. By a purification process of the ORC protein complex, the inventors have identified a new ORC protein complex partner which has been identified to specifically interact with both ORC1 and LRWD1 proteins. They named this protein ORC Ubiquitin-ligase 1 or Obi1.
The invention relates to this protein or derived proteins as drug and to coumpounds affecting (i.e. inhibiting or activating) the expression or the activity of said protein.
- Mots clés DNA replication origins, ORC Ubiquitin-ligase, cancer, orphan diseases
- Secteurs Health
